Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Teva Branded Pharmaceutical Products R&D, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The participant has a diagnosis of asthma for at least 12 months prior to the initial screening visit.
The participant is able to perform technically acceptable and repeatable spirometry, including with a hand-held spirometer, after training
The participant has had at least one documented clinical asthma exacerbation in the 18 months prior to (but not within 30 days of) the initial screening visit.
The participant is a non-smoker for ≥6 months with lifetime history ≤10 pack-years, with no current ecigarette or marijuana use.
NOTE- Additional criteria apply, please contact the investigator for more information
You may not be if
The participant has any concomitant conditions or treatments that could interfere with study conduct.
The participant is currently pregnant or lactating or is planning to become pregnant during the study.
The participant has received any live or attenuated vaccine within 15 days of the initial screening visit.
NOTE- Additional criteria apply, please contact the investigator for more information
Clareo Health | A Study to Test if TEV-48574 is Effective in Relieving Asthma
